Josh is a partner and research analyst at RTW Investments. He specializes in the chemistry of small and large molecules with a focus on immunology and inflammation. Prior to joining RTW, he served as Principal Scientist and Head of Externalization at Schrodinger. Josh began his career at Roche as a medicinal chemist. He received a PhD in Chemistry from University of California, Berkeley and a BS in Chemistry from University of California, Santa Cruz. He has worked globally at sites in the US, Switzerland, and India.